Interference of low-molecular substances with the thioflavin-T fluorescence assay of amyloid fibrils
ABSTRACT Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type‐II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent...
Saved in:
Published in | Journal of peptide science Vol. 18; no. 1; pp. 59 - 64 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.01.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ABSTRACT
Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type‐II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low‐molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid‐β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag‐period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes. Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd.
Basic Blue 41, Basic Blue 12, Azure C and Tannic acid decrease fluorescence intensity of ThT bound to insulin fibrils.
In insulin fibrillization assay monitored by ThT fluorescence, these compounds show apparent inhibition of fibrillization.
Unlike to true inhibitors, these compounds did not decreased the fibrillization rate or increased the lag‐period of insulin fibrillization. |
---|---|
AbstractList | Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type-II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low-molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid-β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag-period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes. ABSTRACT Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type‐II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low‐molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid‐ β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag‐period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes. Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd. ABSTRACT Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type‐II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low‐molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid‐β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag‐period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes. Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd. Basic Blue 41, Basic Blue 12, Azure C and Tannic acid decrease fluorescence intensity of ThT bound to insulin fibrils. In insulin fibrillization assay monitored by ThT fluorescence, these compounds show apparent inhibition of fibrillization. Unlike to true inhibitors, these compounds did not decreased the fibrillization rate or increased the lag‐period of insulin fibrillization. |
Author | Primar, Kateryna Palumaa, Peep Noormägi, Andra Tõugu, Vello |
Author_xml | – sequence: 1 givenname: Andra surname: Noormägi fullname: Noormägi, Andra organization: Department of Gene Technology, Tallinn University of Technology, 12618, Akadeemia 15Tallinn, Estonia – sequence: 2 givenname: Kateryna surname: Primar fullname: Primar, Kateryna organization: Department of Gene Technology, Tallinn University of Technology, 12618, Akadeemia 15Tallinn, Estonia – sequence: 3 givenname: Vello surname: Tõugu fullname: Tõugu, Vello organization: Department of Gene Technology, Tallinn University of Technology, 12618, Akadeemia 15Tallinn, Estonia – sequence: 4 givenname: Peep surname: Palumaa fullname: Palumaa, Peep email: peepp@staff.ttu.ee, peepp@staff.ttu.ee organization: Department of Gene Technology, Tallinn University of Technology, 12618, Akadeemia 15Tallinn, Estonia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22083646$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kF1v2yAUhtHUav2atF8w-W69cctHDPiyitquUtRWTabtDmF8UNmwScFuln8_vKS9mxACcR4enfOeoIM-9IDQZ4IvCMb0cp3MBZkR_gEdE1zXJWFSHEx3UZWUE3GETlL6hXGuVfwjOqIUS8Zn_Bi1d_0A0UKE3kARbOHDpuyCBzN6HYs0NmnQuZSKjRuei-EZ8nbBev3q-nJVWD-GCMn8-65T0ttJorutD64trGui8-kMHVrtE3zan6fo-831av6tXDzc3s2vFqVhleRlI2eGUcMpx2AIaY0UWrZUVsRiVkEFElqWFxf5iZFZ3eR5DFAB1hpCKTtFX3fedQwvI6RBdS635r3uIYxJ1YQJioWcyPMdaWJIKYJV6-g6HbeKYDVFqnKkaoo0o1_20rHpoH0H3zLMQLkDNs7D9r8i9bic74V73qUB_rzzOv5WXDBRqR_3t-pp8ZPVZCkUZn8BhIORmw |
CitedBy_id | crossref_primary_10_1021_ac503845f crossref_primary_10_1002_chem_201704593 crossref_primary_10_1002_psc_3115 crossref_primary_10_3390_pathogens13060452 crossref_primary_10_1021_acs_analchem_6b04266 crossref_primary_10_3233_JAD_181001 crossref_primary_10_1016_j_neuint_2020_104806 crossref_primary_10_1371_journal_pone_0170266 crossref_primary_10_1089_dia_2014_0047 crossref_primary_10_1039_c3mb70201d crossref_primary_10_1039_D0AN02260H crossref_primary_10_1039_C8CC07164K crossref_primary_10_1039_D1AY01126J crossref_primary_10_1089_cbr_2012_1328 crossref_primary_10_3233_ADR_180066 crossref_primary_10_3233_JAD_150790 crossref_primary_10_1016_j_foodhyd_2020_106327 crossref_primary_10_1016_j_ijbiomac_2023_126331 crossref_primary_10_1208_s12248_016_0028_6 crossref_primary_10_1007_s00249_015_1019_8 crossref_primary_10_1016_j_cbpa_2017_06_008 crossref_primary_10_1038_ncomms9997 crossref_primary_10_3233_JAD_190758 crossref_primary_10_1016_j_ijbiomac_2024_133660 crossref_primary_10_1371_journal_pone_0121231 crossref_primary_10_1021_cn300076x crossref_primary_10_1021_acschemneuro_5b00104 crossref_primary_10_7717_peerj_1271 crossref_primary_10_1039_c3an36798c |
Cites_doi | 10.1042/BJ20100627 10.1007/s11095-007-9516-9 10.1016/j.jsb.2004.08.002 10.1016/j.jsb.2007.06.004 10.1016/j.bcp.2009.04.034 10.1021/la063048k 10.1016/j.bbapap.2010.04.001 10.4161/isl.1.3.9609 10.1038/nature02261 10.1111/j.1471-4159.2009.06269.x 10.1021/ac101583q 10.1073/pnas.1002867107 10.1210/en.2010-0457 10.1038/nm0908-894 10.1038/nchembio.131 10.1038/nrd3050 10.1111/j.1742-4658.2009.07307.x 10.1021/jp070590o |
ContentType | Journal Article |
Copyright | Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd. |
Copyright_xml | – notice: Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd. |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1002/psc.1416 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1099-1387 |
EndPage | 64 |
ExternalDocumentID | 10_1002_psc_1416 22083646 PSC1416 ark_67375_WNG_RLX391S7_0 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACIWK ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BLYAC BMNLL BMXJE BNHUX BROTX BRXPI BSCLL BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NDZJH NF~ O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RBB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 UB1 V2E V8K W8V W99 WBFHL WBKPD WIB WIH WIK WJL WOHZO WQJ WRC WSB WXSBR WYISQ XG1 XV2 Y6R ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c3586-b84c32c6260ec11dc87a8d2851f035e5e8ed3d3d678513149b099ce27effc1223 |
IEDL.DBID | DR2 |
ISSN | 1075-2617 |
IngestDate | Fri Aug 16 07:08:24 EDT 2024 Fri Aug 23 02:12:08 EDT 2024 Sat Sep 28 07:50:42 EDT 2024 Sat Aug 24 00:58:58 EDT 2024 Wed Oct 30 09:54:03 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Copyright © 2011 European Peptide Society and John Wiley & Sons, Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3586-b84c32c6260ec11dc87a8d2851f035e5e8ed3d3d678513149b099ce27effc1223 |
Notes | ark:/67375/WNG-RLX391S7-0 istex:63EF4ABBDFFF545594357562E94165BE89633AB8 ArticleID:PSC1416 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 22083646 |
PQID | 913720782 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_913720782 crossref_primary_10_1002_psc_1416 pubmed_primary_22083646 wiley_primary_10_1002_psc_1416_PSC1416 istex_primary_ark_67375_WNG_RLX391S7_0 |
PublicationCentury | 2000 |
PublicationDate | 2012-01 January 2012 2012-Jan 2012-01-00 20120101 |
PublicationDateYYYYMMDD | 2012-01-01 |
PublicationDate_xml | – month: 01 year: 2012 text: 2012-01 |
PublicationDecade | 2010 |
PublicationPlace | Chichester, UK |
PublicationPlace_xml | – name: Chichester, UK – name: England |
PublicationTitle | Journal of peptide science |
PublicationTitleAlternate | J. Pept. Sci |
PublicationYear | 2012 |
Publisher | John Wiley & Sons, Ltd |
Publisher_xml | – name: John Wiley & Sons, Ltd |
References | Krebs MR, Bromley EH, Donald AM. The binding of thioflavin-T to amyloid fibrils: localisation and implications. J. Struct. Biol. 2005; 149: 30-37. Hawe A, Sutter M, Jiskoot W. Extrinsic fluorescent dyes as tools for protein characterization. Pharm. Res. 2008; 25: 1487-1499. Levy-Sakin M, Shreberk M, Daniel Y, Gazit E. Targeting insulin amyloid assembly by small aromatic molecules: toward rational design of aggregation inhibitors. Islets 2009; 1: 210-215. Zovo K, Helk E, Karafin A, Tõugu V, Palumaa P. Label-free high-throughput screening assay for inhibitors of Alzheimer's amyloid-β peptide aggregation based on MALDI MS. Anal. Chem. 2010; 82: 8558-8565. Aguzzi A, O'Connor T. Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat. Rev. Drug Discov. 2010; 9: 237-248. Chiti F, Dobson CM. Amyloid formation by globular proteins under native conditions. Nat. Chem. Biol. 2009; 5: 15-22. Tougu V, Karafin A, Zovo K, Chung RS, Howells C, West AK, Palumaa P. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. J. Neurochem. 2009; 110: 1784-1795. Gura T. Hope in Alzheimer's fight emerges from unexpected places. Nat. Med 2008; 14: 894. Wolfe LS, Calabrese MF, Nath A, Blaho DV, Miranker AD, Xiong Y. Protein-induced photophysical changes to the amyloid indicator dye thioflavin T. Proc. Natl. Acad. Sci. U. S. A. 2010; 107: 16863-16868. Stsiapura VI, Maskevich AA, Kuzmitsky VA, Turoverov KK, Kuznetsova IM. Computational study of thioflavin T torsional relaxation in the excited state. J. Phys. Chem. A 2007; 111: 4829-4835. Bolder SG, Sagis LMC, Venema P, van der Linden E. Thioflavin T and birefringence assays to determine the conversion of proteins into fibrils. Langmuir 2007; 23: 4144-4147. Lasagna-Reeves CA, Clos AL, Midoro-Hiriuti T, Goldblum RM, Jackson GR, Kayed R. Inhaled insulin forms toxic pulmonary amyloid aggregates. Endocrinology 2010; 151: 4717-4724. Dobson CM. Protein folding and misfolding. Nature 2003; 426: 884-890. Groenning M, Norrman M, Flink JM, van de Weert M, Bukrinsky JT, Schluckebier G, Frokjaer S. Binding mode of Thioflavin T in insulin amyloid fibrils. J. Struct. Biol. 2007; 159: 483-497. Oz M, Lorke DE, Petroianu GA. Methylene blue and Alzheimer's disease. Biochem. Pharmacol. 2009; 78: 927-932. Hudson SA, Ecroyd H, Kee TW, Carver JA. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. 2009; 276: 5960-5972. Noormagi A, Gavrilova J, Smirnova J, Tougu V, Palumaa P. Zn(II) ions co-secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin. Biochem. J. 2010; 430: 511-518. Biancalana M, Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta 2010; 1804: 1405-1412. 2009; 78 2007; 159 2003; 426 2010; 107 2007; 111 2005; 149 2009; 110 2008; 25 2008; 14 2010; 430 2009; 276 2010; 1804 2010; 151 2009; 5 2009; 1 2007; 23 2010; 9 2010; 82 e_1_2_6_10_1 e_1_2_6_9_1 e_1_2_6_8_1 e_1_2_6_19_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_3_1 e_1_2_6_11_1 e_1_2_6_2_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 |
References_xml | – volume: 149 start-page: 30 year: 2005 end-page: 37 article-title: The binding of thioflavin‐T to amyloid fibrils: localisation and implications publication-title: J. Struct. Biol. – volume: 1804 start-page: 1405 year: 2010 end-page: 1412 article-title: Molecular mechanism of Thioflavin‐T binding to amyloid fibrils publication-title: Biochim. Biophys. Acta – volume: 111 start-page: 4829 year: 2007 end-page: 4835 article-title: Computational study of thioflavin T torsional relaxation in the excited state publication-title: J. Phys. Chem. A – volume: 9 start-page: 237 year: 2010 end-page: 248 article-title: Protein aggregation diseases: pathogenicity and therapeutic perspectives publication-title: Nat. Rev. Drug Discov. – volume: 430 start-page: 511 year: 2010 end-page: 518 article-title: Zn(II) ions co‐secreted with insulin suppress inherent amyloidogenic properties of monomeric insulin publication-title: Biochem. J. – volume: 14 start-page: 894 year: 2008 article-title: Hope in Alzheimer's fight emerges from unexpected places publication-title: Nat. Med – volume: 1 start-page: 210 year: 2009 end-page: 215 article-title: Targeting insulin amyloid assembly by small aromatic molecules: toward rational design of aggregation inhibitors publication-title: Islets – volume: 151 start-page: 4717 year: 2010 end-page: 4724 article-title: Inhaled insulin forms toxic pulmonary amyloid aggregates publication-title: Endocrinology – volume: 23 start-page: 4144 year: 2007 end-page: 4147 article-title: Thioflavin T and birefringence assays to determine the conversion of proteins into fibrils publication-title: Langmuir – volume: 5 start-page: 15 year: 2009 end-page: 22 article-title: Amyloid formation by globular proteins under native conditions publication-title: Nat. Chem. Biol. – volume: 25 start-page: 1487 year: 2008 end-page: 1499 article-title: Extrinsic fluorescent dyes as tools for protein characterization publication-title: Pharm. Res. – volume: 82 start-page: 8558 year: 2010 end-page: 8565 article-title: Label‐free high‐throughput screening assay for inhibitors of Alzheimer's amyloid‐β peptide aggregation based on MALDI MS publication-title: Anal. Chem. – volume: 159 start-page: 483 year: 2007 end-page: 497 article-title: Binding mode of Thioflavin T in insulin amyloid fibrils publication-title: J. Struct. Biol. – volume: 426 start-page: 884 year: 2003 end-page: 890 article-title: Protein folding and misfolding publication-title: Nature – volume: 78 start-page: 927 year: 2009 end-page: 932 article-title: Methylene blue and Alzheimer's disease publication-title: Biochem. Pharmacol. – volume: 107 start-page: 16863 year: 2010 end-page: 16868 article-title: Protein‐induced photophysical changes to the amyloid indicator dye thioflavin T publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 276 start-page: 5960 year: 2009 end-page: 5972 article-title: The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds publication-title: FEBS J. – volume: 110 start-page: 1784 year: 2009 end-page: 1795 article-title: Zn(II)‐ and Cu(II)‐induced non‐fibrillar aggregates of amyloid‐beta (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators publication-title: J. Neurochem. – ident: e_1_2_6_6_1 doi: 10.1042/BJ20100627 – ident: e_1_2_6_9_1 doi: 10.1007/s11095-007-9516-9 – ident: e_1_2_6_8_1 doi: 10.1016/j.jsb.2004.08.002 – ident: e_1_2_6_17_1 doi: 10.1016/j.jsb.2007.06.004 – ident: e_1_2_6_18_1 doi: 10.1016/j.bcp.2009.04.034 – ident: e_1_2_6_12_1 doi: 10.1021/la063048k – ident: e_1_2_6_10_1 doi: 10.1016/j.bbapap.2010.04.001 – ident: e_1_2_6_15_1 doi: 10.4161/isl.1.3.9609 – ident: e_1_2_6_4_1 doi: 10.1038/nature02261 – ident: e_1_2_6_7_1 doi: 10.1111/j.1471-4159.2009.06269.x – ident: e_1_2_6_13_1 doi: 10.1021/ac101583q – ident: e_1_2_6_5_1 doi: 10.1073/pnas.1002867107 – ident: e_1_2_6_16_1 doi: 10.1210/en.2010-0457 – ident: e_1_2_6_19_1 doi: 10.1038/nm0908-894 – ident: e_1_2_6_2_1 doi: 10.1038/nchembio.131 – ident: e_1_2_6_3_1 doi: 10.1038/nrd3050 – ident: e_1_2_6_14_1 doi: 10.1111/j.1742-4658.2009.07307.x – ident: e_1_2_6_11_1 doi: 10.1021/jp070590o |
SSID | ssj0009956 |
Score | 2.143875 |
Snippet | ABSTRACT
Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's... Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as... |
SourceID | proquest crossref pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 59 |
SubjectTerms | aggregation amyloid Amyloid - analysis Amyloid - metabolism Amyloid beta-Peptides - analysis Amyloid beta-Peptides - metabolism Azure Stains - adverse effects Azure Stains - metabolism Biological Assay Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - metabolism False Positive Reactions fibrillization fluorescence Fluorescent Dyes - analysis Fluorescent Dyes - metabolism Humans insulin Insulin - analysis Insulin - metabolism Kinetics Neurodegenerative Diseases - diagnosis Neurodegenerative Diseases - metabolism Protein Structure, Secondary Spectrometry, Fluorescence Tannins - adverse effects Tannins - metabolism Thiazoles - analysis Thiazoles - antagonists & inhibitors Thiazoles - metabolism |
Title | Interference of low-molecular substances with the thioflavin-T fluorescence assay of amyloid fibrils |
URI | https://api.istex.fr/ark:/67375/WNG-RLX391S7-0/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpsc.1416 https://www.ncbi.nlm.nih.gov/pubmed/22083646 https://search.proquest.com/docview/913720782 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5VVGp7KY9SWFqQkareAmvn4eRYbXkIAap4qCtxsBzHFitCgja7bempP6G_sb-kM3ksoioSQlGUizNxPGP7sz3zDcCHLMoytBTn0SGah_g_8VJupGeTNDIusVLGFJx8dBztnwcHw3DYelVSLEzDDzHbcKOeUY_X1MF1Wm3fkYbeVAa7OSe2be5L8ub6fHLHHEUBm427ITlxcdnxzvbFdvfivZnoOTXqj__BzPuotZ52dufhoqtw421ytTWdpFvm5z9cjk_7owV43aJR9qkxn0V4ZosleDnoksAtwYuj9uz9DVzWm4dteCArHcvL739-_b7u8uuyCsegCRlRxWh3lyG0xHtUulx_GxVY9Iy5fFqOawIpFIGwXd-SIH19m5ejjDkKP8irZTjf3Tkb7HttngbP-GEceWkcGF8YWhpZw3lmYqnjTCCWc30_tKGNbebjhfNiyH1ckqWoHmOFtM4ZjvjkLcwVZWFXgQU69aVDaRHCHB0YHWXC9RM0tCgS2ogebHY6UzcNHYdqiJeFwuZT1Hw9-Fgrc1ZAj6_IfU2G6uvxnjo5HPoJP5Wq3wPWaVths9JJiS5sOa1Uwil5D4KnHqw0VjATJgTxeQf0lVqXD1ZDfTkd0HPtsQXfwStEY6LZ33kPc5Px1K4j4pmkG7Vt_wUsHP8l |
link.rule.ids | 315,783,787,1378,27938,27939,46308,46732 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwED-NTWJ74c-AUf4aCfGWrXESOxFPqDAKtBXaOtEHJMtxbFEtS6amBbanfQQ-I5-Eu6TpNAQSQlGUF8dxfGf75_Pd7wCeZyLLUFOcR4doHuL_xEt9Iz2bpMK4xEoZU3DycCT6R-H7STRZg5dtLEzDD7EyuNHIqOdrGuBkkN67ZA09rQyOc19cgw0c7QGlL3h9cMkdRSGbjcMhuXH5smWe7fK99s0ra9EGdev3PwHNq7i1Xnj2b8LntsmNv8nx7mKe7prz39gc__OfbsGNJSBlrxoNug1rttiGzV6bB24brg-Xx-934EttP1xGCLLSsbz89vPix0mbYpdVOA3NSY8qRgZehugS72npcv11WmDRMXP5opzVHFJYBSJ3fUYV6ZOzvJxmzFEEQl7dhaP9N-Ne31umavBMEMXCS-PQBNzQ7sga389MLHWccYRzrhtENrKxzQK8cGmM_AB3ZSnKx1gurXPGR4hyD9aLsrD3gYU6DaTD2gQiHR0aLTLuugnqmhBcG96BZ63Q1GnDyKEa7mWusPsUdV8HXtTSXBXQs2PyYJOR-jR6qw4GkyDxD6XqdoC14lbYrXRYogtbLiqV-JS_B_FTB3YaNVhVxjlReof0lVqYf22G-njYo-eDfy34FDb74-FADd6NPjyELQRnvDH3PIL1-WxhHyMAmqdPakX_BQZDA04 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BKxUuPMpreRoJcUsbO4mTHNGWpUC7qvoQK3GwHMcWq6bJarMLlBM_gd_IL2Emj62KQEIoinJxJo5nbH-2Z74BeJHLPEdLcR4donmI_1Mv4yb2bJpJ41IbxwkFJ--P5e5J-G4STTqvSoqFafkhVhtu1DOa8Zo6-Cx32xekobPaYDfn8iqshzLwyZ1r5_CCOooiNlt_Q_Li4nFPPOuL7f7NS1PROrXq1z_hzMuwtZl3RjfhY1_j1t3kdGu5yLbMt9_IHP_vl27BjQ6Oslet_dyGK7bchGvDPgvcJmzsd4fvd-BTs3vYxQeyyrGi-vLz-4-zPsEuq3EQWpAV1Yy2dxliS7ynlSv052mJRY-ZK5bVvGGQQhGI2_U5CdJn50U1zZmj-IOivgsno9fHw12vS9TgmSBKpJcloQmEobWRNZznJol1kgsEc84PIhvZxOYBXjgxRjzANVmG6jFWxNY5wxGg3IO1sirtA2ChzoLYoTSJOEeHRstcOD9FS5NSaCMG8LzXmZq1fByqZV4WCptPUfMN4GWjzFUBPT8l_7U4Uh_Gb9Th3iRI-VGs_AGwXtsKm5WOSnRpq2WtUk7ZexA9DeB-awUrYUIQoXdIX2l0-ddqqIOjIT0f_mvBZ7BxsDNSe2_H7x_BdURmot3reQxri_nSPkH0s8ieNmb-CwinAf0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interference+of+low%E2%80%90molecular+substances+with+the+thioflavin%E2%80%90T+fluorescence+assay+of+amyloid+fibrils&rft.jtitle=Journal+of+peptide+science&rft.au=Noorm%C3%A4gi%2C+Andra&rft.au=Primar%2C+Kateryna&rft.au=T%C3%B5ugu%2C+Vello&rft.au=Palumaa%2C+Peep&rft.date=2012-01-01&rft.issn=1075-2617&rft.eissn=1099-1387&rft.volume=18&rft.issue=1&rft.spage=59&rft.epage=64&rft_id=info:doi/10.1002%2Fpsc.1416&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_psc_1416 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1075-2617&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1075-2617&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1075-2617&client=summon |